Filter
189
Text search:
biotechnology
Featured
Recommendations
15
New Publications
43
Language
Document type
No document type
87
Studies & Reports
50
Guidelines
27
Manuals
16
Fact sheets
6
Training Material
1
Situation Updates
1
Strategic & Response Plan
1
Countries / Regions
India
28
Global
10
Nepal
4
South Africa
4
Bangladesh
4
Western and Central Europe
4
Nigeria
3
Ethiopia
3
USA
2
Germany
2
Tanzania
2
Rwanda
2
Myanmar / Burma
2
West and Central Africa
2
South–East Asia Region
2
Asia
2
Russia
2
Sierra Leone
1
Liberia
1
Cameroon
1
Uganda
1
Zimbabwe
1
Philippines
1
Iraq
1
Zambia
1
Syria
1
Kenya
1
Cambodia
1
Thailand
1
Malawi
1
Mozambique
1
Ukraine
1
Colombia
1
Botswana
1
Libya
1
East and Southern Africa
1
Eastern Europe and Central Asia
1
Africa
1
Iran
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
66
Clinical Guidelines
16
Key Resources
9
Pharmacy & Technologies
8
Women & Child Health
5
Public Health
2
Capacity Building
1
Toolboxes
COVID-19
21
TB
14
Planetary Health
13
AMR
12
Pharmacy
12
Rapid Response
11
NTDs
8
Ebola & Marburg
7
Caregiver
6
HIV
5
Health Financing Toolbox
4
2.0 Rapid Response
4
Refugee
3
Mental Health
3
Specific Hazards
3
Global Health Education
3
NCDs
3
Malaria
3
Disability
2
Conflict
2
Social Ethics
2
Cholera
1
Zika
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
First Revised Edition
March 2000
A Policy analysis
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that
...
This guidance covers different options for banning or phasing out a pesticide and suggests related risk reduction measures to be taken during the phase-out period. A key focus of this guidance is how to take action to manage, prevent, minimize, and communicate about identified risks during the imple
...
This guidance synthesizes current evidence on dengue laboratory testing and diagnostics and provides practical recommendations for laboratories, clinicians, public health officials, and programme managers involved in dengue diagnosis, surveillance, and control, in the context of the global emergency
...
